Adjuvance on forefront of COVID-19 vaccine battle

By Macy Meyer at klkntv.com

Adjuvance is developing a component that will strengthen a vaccine and prolong its dosage.

Tucked away in one of the many labs on Nebraska’s Innovation Campus lays the company Adjuvance. At the beginning of the year they were asked by the National Institute of Health to join in on the global race to fight COVID–19. Four months later they’re making strides.

PHRMA Highlights Industry Work on COVID-19

PhRMA – Our nation’s pharmaceutical industry, including many of Bio Nebraska’s own members, is working collectively to combat COVID-19 across the globe. Bio Nebraska member, PhRMA, highlights that work.

POSTPONED: Bio Nebraska Annual Meeting

To ensure the safety of our participants and guests, we will be postponing our Annual Meeting at UNMC’s Davis Global Center, originally scheduled for April 28, for a later date. Please continue to check our website for updated information.

BIO Coronavirus Hub FAQS

The BIO Coronavirus Hub was launched by the Biotechnology Innovation Organization (BIO), to connect companies and organizations that have relevant supplies, capacities, and resources to share, with those companies, researchers, or healthcare providers in need of those items.

Nebraska Medicine starts clinical trials for coronavirus treatment

Rob Owen, our executive director, spoke to Fox 42 KPTM yesterday about how clinical trials, like the University of Nebraska Medical Center announcement to start clinical trials for treatment of the Coronavirus, help to save lives while giving a boost to the Nebraska economy.